🏛️ Verified NIH Record • Updated 2026-04-27
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS (NCT04482894)
Palliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or High-Risk Myelodysplastic Syndrome: Randomized Phase II Study
🔵 Active, Not Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: University of Virginia
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to estimate the potential benefit of early and continued palliative care (PC) consultation on end of life issues.
Who can join: Review the eligibility criteria below.
Location: University of Virginia — Charlottesville, Virginia
Age range: 18 Years
🧪 Interventions in This Study
- Palliative Care Visits (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Virginia — Charlottesville, Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Leukemia, Acute
- Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients — Baltimore, Maryland
- Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention — Boston, Massachusetts
- Frailty Phenotype Assessments to Optimize Treatment Strategies for Older Patients With Hematologic Malignancies — Philadelphia, Pennsylvania
Explore by condition: All Leukemia, Acute clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.